Physician profile
Munzer Abdulhak
NPI 1316155864
$718.20
in general payments reported to CMS, 2019-2025
16 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $100 · 2020: $52.96 · 2021: $85.04 · 2022: $38.05 · 2023: $168 · 2024: $142 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $442.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $442.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $240.73 | 2023-2025 | Tecnis Simplicity, Tecnis Iol, Veritas Vision System |
| Alcon Vision LLC | $66.29 | 2019-2021 | |
| Apellis Pharmaceuticals, INC. | $54.00 | 2025 | Syfovre |
| Abbvie INC. | $49.31 | 2022-2023 | Durysta |
| Ocular Therapeutix, INC. | $39.13 | 2023 | Dextenza |
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $35.77 | 2021 | |
| Horizon Therapeutics Plc | $32.27 | 2023 | Tepezza |
| Glaukos Corporation | $27.80 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $24.62 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $22.88 | 2019 | |
| Rayner Intraocular Lenses Limited | $21.47 | 2023 | Omidria, Rayone Spheric, Rayone Emv |
| Allergan, INC. | $20.50 | 2019 | |
| Oyster Point Pharma, INC. | $18.66 | 2022 | |
| Kala Pharmaceuticals, INC. | $14.16 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Munzer Abdulhak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.